Machine learning in classification of AML, ag...

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ...  Show more

In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ...  Show more

Send us Fan MailNinja Nerds,Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Acute Leukemias, breaking down their pathophysiology, clinical presentation, and management. We explore the key differences between Acute Myeloid Leukemia (AML) and ...  Show more

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...

This week, we continue our series focusing on acute myeloid leukemia. In this episode, we talk about maintenance therapies in AML.

Episode contents:

- A recap of cytarabine consolidation

- Why do we do maintenance therapy?

- What are hypomethylating a ...

This week’s episode will be focusing on Acute Lymphoblastic Leukemia (ALL). We will go over quick facts on the diagnosis, prognostic factors, and treatment options for both B-cell & T-cell acute lymphoblastic leukemias.